高效液相色谱法测定安立生坦片的有关物质

王博a,李洪起a,连潇嫣a,孟策a,任晓文b

中国药学杂志 ›› 2015, Vol. 50 ›› Issue (6) : 541-544.

PDF(818 KB)
PDF(818 KB)
中国药学杂志 ›› 2015, Vol. 50 ›› Issue (6) : 541-544. DOI: 10.11669/cpj.2015.06.017
论著

高效液相色谱法测定安立生坦片的有关物质

  • 王博a,李洪起a,连潇嫣a,孟策a,任晓文b
作者信息 +

RP-HPLC Assay Method for Related Substances of Ambrisentan Tablets

  • WANG Boa, LI Hong-qia, LIAN Xiao-yana, MENG Cea, REN Xiao-wenb
Author information +
文章历史 +

摘要

目的 建立安立生坦片有关物质的检测方法。方法 采用高效液相梯度洗脱,色谱柱为Agela Venusil MP C18柱( 4.6 mm×250 mm,5 μm),以0.02 mol·L-1磷酸二氢钾溶液(用磷酸调节pH至3.0)-乙腈(62∶38)为流动相A、乙腈为流动相B;流速为1.0 mL·min-1;检测波长为220 nm;柱温35 ℃。结果 在酸、碱、热、氧化破坏条件下,安立生坦产生不同程度的降解,采用建立的方法可有效检出降解产物;安立生坦与各杂质分离良好,经验证该方法的专属性、线性、耐用性等良好。结论 建立的方法可较好地分离、检测出安立生坦片中的各主要杂质,可用于本品有关物质的检查。

Abstract

OBJECTIVE To establish an HPLC method for determination of the related substances of ambrisentan tablets. METHODS Gradient elution was performed on an Agela Venusil MP C18 column (4.6 mm×250 mm, 5 μm). The mixture of 0.02 mol·L-1 phosphate buffer (pH 3.0) and acetonitrile (62∶38) was used as mobile phase A, and acetonitrile as mobile phase B. The flow rate was 1.0 mL·min-1; the detection wavelength was set at 220 nm; and the column temperature was maintained at 35 ℃.RESULTS After being treated with acid, base, heat, and oxidation, ambrisentan underwent more or less degradation. The method could effectively detect the degradation products of ambrisentan; the separation of impurities was good; the method had good specificity, linearity, and durability. CONCLUSION The proposed method can be used to separate and determine the related substances of ambrisentan tablets, and is suitable for the quality control of this drug.

关键词

安立生坦 / 有关物质 / 高效液相梯度洗脱 / 杂质G

Key words

ambrisentan / related substance / HPLC gradient elution / impurity G

引用本文

导出引用
王博a,李洪起a,连潇嫣a,孟策a,任晓文b. 高效液相色谱法测定安立生坦片的有关物质[J]. 中国药学杂志, 2015, 50(6): 541-544 https://doi.org/10.11669/cpj.2015.06.017
WANG Boa, LI Hong-qia, LIAN Xiao-yana, MENG Cea, REN Xiao-wenb. RP-HPLC Assay Method for Related Substances of Ambrisentan Tablets[J]. Chinese Pharmaceutical Journal, 2015, 50(6): 541-544 https://doi.org/10.11669/cpj.2015.06.017
中图分类号: R917   

参考文献

[1] LIU W F, FU D X, HU X. Pharmacology and clinical study of ambrisentan for treatment of pulmonary arterial hypertension[J]. Chin New Drug J(中国新药杂志),2008,17(23):2070-2077.[2] Ch.P(2010)Vol II(中国药典2010年版. 二部)[S]. 2010:附录204-205.[3] NAMASANI S K, AVULA P R, TELU V, et al. Extractive spectrophotometric determination of ambrisentan [J]. Adv Pharm Bull, 2013, 3(1):231-237.[4] DOUSA M, GIBALA P. Rapid determination of ambrisentan enantiomers by enantioselective liquid chromatography using cellulose based chiral stationary phase in reverse phase mode[J]. J Sep Sci, 2012, 35(7):798-803.[5] NARAYANAL M B,CHANDRASEKHAR K B, RAO B M. A validated specific stability-indicating RP-HPLC assay method for ambrisentan and its related substances[J]. J Chromatogr Sci,2014,52(8):818-825.[6] SFDA. Technical Guidelines for Chemical Drug Impurities (化学药物杂质研究的技术指导原则) [EB/OL]. SFDA. 2005. [2014-09]. http://www. sfda. gov. cn/WS01/CL1616/83416.html.
PDF(818 KB)

Accesses

Citation

Detail

段落导航
相关文章

/